SlideShare a Scribd company logo
© PROJECT INFORM 1375 MISSION STREET SAN FRANCISCO, CA 94103-2621 415-558-8669 FAX 415-558-0684 SUPPORT@PROJECTINFORM.ORG WWW.PROJECTINFORM.ORG
MAKING DECISIONS
ABOUT THERAPIES

issues to consider
when developing your
personal treatment plan
Making decisions about treating HIV can sometimes feel overwhelming.
Developing a personal plan to help you think about, plan for and make
treatment decisions can help. Whether considering pharmaceutical drugs
or complementary therapies, it’s important that your plan is one you’re
comfortable with and feel empowered by. This publication focuses on issues
to consider when developing your treatment decision-making plan.
WHAT’S INSIDE
The basis for making a decision: 2; Choosing a doctor: 3; Learn about HIV disease and your treatment options: 4–5; Information, consider the
source: 5; Once you’ve made a treatment decision, consider ... : 6–7; Choosing the best time to start: 6; The power of the mind: 7; Some final words
on making decisions: 8.
PUBLISHED BY
JANUARY 2007
TOLL-FREE NATIONAL HIV/AIDS TREATMENT HOTLINE 1-800-822-7422 LOCAL AND INTERNATIONAL 415-558-9051 MONDAY–FRIDAY 10–4 PACIFIC TIME
MAKINGDECISIONS.JANUARY2007.PROJECTINFORM
2
the basis for making decisions
Regardless of the therapy you consider, the same basic
principals for making decisions can be used, including:
 CHOOSE AN EXPERIENCED PROVIDER.
Choose a healthcare provider or doctor
who is experienced with the treatment of
HIV disease and with the types of therapy
you are interested in pursuing.
 DEVELOP THE RIGHT RELATIONSHIP.
Learn about the different types of doctor/
patient relationships; determine how you
want to interact with your doctor and
develop the right relationship. Discuss
your decision-making process style of
relationship with your healthcare provider.
 GET INFORMED! Learn about your
health condition(s) and possible treatment
options:
sources of information that give you objective information about various treatments
and strategies. Project Inform offers this kind of information free-of-charge through
a toll-free hotline, printed documents, public meetings and website.
 TALK BEFORE YOU START. Talk to your doctor before you start therapy
(regardless of what that therapy is) and come to mutual agreements about:
© PROJECT INFORM 1375 MISSION STREET SAN FRANCISCO, CA 94103-2621 415-558-8669 FAX 415-558-0684 SUPPORT@PROJECTINFORM.ORG WWW.PROJECTINFORM.ORG
MAKINGDECISIONS.JANUARY2007.PROJECTINFORM
3
Finding a doctor who has experience
treatingpeoplelivingwithHIVisvery
important. Studies have shown that
people with HIV who see doctors
experienced in treating people with
HIV are more likely to be long-term
survivors than those with inexperi-
enced doctors.
According to these studies, an
HIV-experienced doctor is someone
who has five or more people in their
practice who are living with HIV,
though in general, the more experi-
ence and patients the physician has,
the better. Consider five a minimum.
Experienced doctors will usually
have more skill in prescribing and
monitoring anti-HIV drugs wisely,
and are also more likely to wisely
prescribed preventative therapies.
cological and pregnancy concerns,
choosing an experienced gynecologist
and/or obstetrician is also important.
In some cases, choosing a highly
HIV-experienced doctor is not poss-
ible. This is especially true in rural
settings where HIV-positive people
may be more isolated than in major
cities. This does not mean that one
need receive less than optimal care.
Even in the most rural settings,
there is usually at least one healthcare
provider who has worked with HIV-
positive people. Some experience is
better than none. However, it may
mean that the patient and doctor need
to be more diligent in learning about
HIV, keeping up to date on the latest
in treatment information and finding
appropriate resources. Developing an
open and comfortable relationship
will help this ongoing process.
Often, people liv-
ing with HIV in such
situa-tions play an
important role in keep-
ing their doctors up to
date by bringing them
new information, reports
from medical conferences and
resources available from groups like
Project Inform. While doctors may
some-times at first be inclined to
reject information from anyone other
than doctors, they often get over this
prejudice when they realize that, at
least in HIV disease, community
groups andresourcesoftenhavebetter
accessto information, and more time
for reviewing it, than they do. Many
physicians come to welcome the
input their patients can bring them.
Finally, the general principal of
choosing an HIV-experienced doctor
applies to practitioners of alternative
systems of healing as well, like tra-
ditional Chinese medicine, herbal-
ists, acupuncturists and other holis-
tic healers. If you have an interest in
complimentary or alternative thera-
pies, the healthcare provider should
have experience in their use in HIV-
positive people, not just experience
with therapies themselves.
Some herbs and supplements, for
example, can affect the way commonly
used anti-HIV drugs are absorbed
in the body, so knowledge of both
types of therapy is critical. A doctor
or healing practitioner who keeps
up to date on literature about new
discov-eries in our understanding
of HIV disease and who has expe-
rience treating people living with
HIV is an important partner in your
healthcare.
developing a relationship
with your doctor
Working with your provider to develop a relationship that you both feel
comfortable with is the next step. It’s important to trust your own reac-
tions when deciding whether this doctor is the right one for you. But
you also may want to give the relationship some time to develop. It takes
more than one visit for you and your doctor to get to know each other.
For more information on developing a relationship with a doctor, call
Doctor/Patient Relationship.
Choosing a doctor
TOLL-FREE NATIONAL HIV/AIDS TREATMENT INFORMATION HOTLINE 1-800-822-7422 LOCAL/INTERNATIONAL 415-558-9051 MONDAY-FRIDAY 9-5 SATURDAY 10-4 PACIFIC TIME
MAKINGDECISIONS.JANUARY2007.PROJECTINFORM
4
TOLL-FREE NATIONAL HIV/AIDS TREATMENT HOTLINE 1-800-822-7422 LOCAL AND INTERNATIONAL 415-558-9051 MONDAY–FRIDAY 10–4 PACIFIC TIME
A key to participating in treatment decision making is to get informed about
HIV disease, treatment options and overall strategies sooner rather than later.
If a person waits too long before seeking medical care and has already come down
with an opportunistic infection, there may be little time to learn about options since
immediate treatment may be needed.
Whenever possible, people should get informed about treatment strategies and
option well before it’s time to start treatment.For more information about monitoring
HIV disease, call Project Inform’s Hotline and ask for Day One.
If you’re healthy and not feeling like you need or want to start therapy immediately, it’s
still a good idea to learn about your treatment options and strategies and begin talking
with your doctor about what to do and when to do it. Making those decisions before the problem is critical can
diminish some of the fear that is often associated with starting any kind of therapy for the first time. Starting these
discussions with your doctor is perhaps the best form of “early intervention” and will greatly increase the chances
that you will avoid starting therapy either too early or too late.
What does the research show?
Getting informed and learning about HIV and your options
and strategies may seem overwhelming at first. It’s not easy
for anyone. Sometimes it’s hard to read about HIV disease
and the information may sometimes seem like it’s written in
a foreign language ... at first!
One of the missions ofProject Inform is to provide under-
standable information to people living with HIV. The staff
at Project Inform spends hundreds of hours annually in
medical libraries, attending medical conferences and ana-
lyzing studies to learn about the latest advances and what
they mean. We try our best to put that information together
in a way that people who aren’t scientists or doctors can
understand it.
Some people think of Project Inform as a sort of Consumer
Reports on HIV treatments. Though we do everything we can
to make it the best source, Project Inform is not the only
place to get information about HIV treatments and strate-
gies, however. There are several newsletters and sources of
HIV information, each with its own special benefits.
For a list of references, call Project Inform’s Hotline and
ask for Guide to HIV/AIDS Related Resources. The Project
Inform Hotline operates Monday through Friday and vol-
-
tions you might have and mail you information, free of charge.
Explore, examine and challenge
your beliefs about therapy.
Most people have concerns and fears about starting therapies,
be they anti-HIV therapies or complementary herbal ther-
apies. Learning about that therapy can sometimes lessen
your concerns and help you decide whether it’s right for you.
Consider how it might impact your lifestyle and whether any
dietary restrictions may be a problem. Learn about poten-
tial side effects and prepare for them, should they occur.
In exploring your beliefs about a therapy, you might find
that you have come to a conclusion based on personal fears
or rumors. Grounding yourself in knowledge, rather than
fears, and challenging where possibly unfounded beliefs might
be clouding decision-making is critical. Challenging your
beliefs and seeking their roots is important. Personal experi-
ence and knowledge about a given therapy is far better infor-
mation to inform decision-making than fears or conjecture.
With that said, however, if you truly believe that a parti-
cular approach may be more harmful to you than its poten-
tial benefits, you might be better off considering another
option. You can always revisit that decision at a later time.
Don’t reject what you believe about therapy when it comes
to making your decision—it should weigh in with other
considerations but those beliefs should be explored, exam-
ined and challenged.
Get informed!
Learn about HIV disease and ...
© PROJECT INFORM 1375 MISSION STREET SAN FRANCISCO, CA 94103-2621 415-558-8669 FAX 415-558-0684 SUPPORT@PROJECTINFORM.ORG WWW.PROJECTINFORM.ORG
MAKINGDECISIONS.JANUARY2007.PROJECTINFORM
5
What has been the experience
of friends and people you trust?
Learning about other people’s experience with a particular
therapy or treatment-decision plan can help inform your
own decisions. Talk to friends, people in support groups
and others who are experiencing similar health conditions.
Ask them about what kinds of treatments they’re using.
Why did they choose those treatments and what have their
But great caution should also be exercised when using
the experiences of others as a source of information. The
fewer people you ask, the less reliable that information will
be. Remember, what works for one person won’t always
work for you. Just because someone you know had a bad
experi-ence—or a good one—with a particular therapy
doesn’t mean that you will.
There are many factors beyond our control that affect how
each of us responds to a particular treatment strategy. The
personal experiences of others should be only a piece of the
pie as you gather information. The most reliable picture of a
therapy’s actions will usually come from well-designed stud-
ies, but even these cannot predict how you will respond.
Does your healthcare provider have an opinion
about the therapy option or strategy you’re con-
sidering? If so, what is it and what is it based on?
Ask your doctor about his or her experience with or opin-
ions about the therapies and strategies you are considering.
Does the doctor have advice about whether a particular
about the different options you are hearing about and the
information reported in sources such as newsletters.
If you find that your doctor likes to put everyone on
the same treatment, ask why. HIV treatment information
and guidelines are not meant to be a cookbook, to be used
the same way with everyone. Ask how you might develop
a treat-ment strategy that takes your personal needs and
concerns in mind. For more information on developing a
relationship with your doctor, call Project Inform’s Hotline
and ask for Building a Doctor/Patient Relationship.
You can’t make an informed decision about treatments—
regardless of what type of treatment you’re considering—if
you’re not informed about all your options. Get as much
information as possible, from a variety of credible sources
that you trust. Learn about HIV and treatment options.
It’s better to make an informed decision that you feel very
com-fortable with than a hasty one.
your treatment options!
Information: consider the source
As you’re learning about HIV and possible
treatment approaches, be aware of false
and misleading medical information and
claims about therapies. When you’re
reading about HIV and HIV treatments,
consider the source of the information.
Pharmaceuticalcompaniesthatmarket
HIV therapies have an interest in selling
products and may not always provide a
balanced view of their products. Pharma-
ceutical company advertising should be
viewed with skepticism.
Increasingly, community and physician
forumsandeducationalmaterialsarebeing
paid for with pharmaceutical money. Just
because a pharmaceutical company sup-
ports an educational forum doesn’t auto-
matically mean that the information isn’t
useful;butyouhavearighttoaskquestions
about the speaker’s involvement with the
company—likewhetherornottheyreceived
money from the company. Consider how
thatmightinfluencetheirabilitytoprovide
unbiased information.
There are many people who, under the
guiseofalternative/complementaryther-
apies, propose to have “cures” for HIV,
cancer and many other life-threatening
diseases. Often they will claim that they
have a therapy that is being suppressed,
shrouded in controversy and government
conspiracy. In reality the vast majority of
allsuchclaimsareoutrightfraud.Innearly
all cases, individuals prey on the vulner-
abilityandhopesofpeoplewhoarefright-
ened and make a pretty penny in doing
so. For more information, read Project
Inform’s How To Identify AIDS Fraud.
TOLL-FREE NATIONAL HIV/AIDS TREATMENT HOTLINE 1-800-822-7422 LOCAL AND INTERNATIONAL 415-558-9051 MONDAY–FRIDAY 10–4 PACIFIC TIME
MAKINGDECISIONS.JANUARY2007.PROJECTINFORM
6
When to start?
Starting any ther-
apy can cause anxi-
ety. There is no one
proven “right” time to
start anti-HIV therapy,
for example, for everyone.
There are differing opinions about
starting therapy early in the course of
HIV infection vs. later. Either choice
In general, current thinking in the
US and Europe is leaning in favor of
delaying treatment until there has been a
significant decline on CD4+ cell counts.
The most recent research shows that
this loss can usually be recovered when
people start treatment.
In contrast, starting treatment very
early, before significant decline of CD4+
cell counts, can force people to begin
using up the limited time that each
drug will work, earlier than necessary.
It may also lead to an earlier risk of
developing both drug side effects and
drug resistance. These cannot always be
corrected so easily. (For more informa-
tion, call Project Inform’s Hotline and
ask for Anti-HIV Therapy Strategies).
While there are instances where
using anti-HIV therapies have clearly
been shown to be beneficial, when to
start therapy remains an individual
decision. Most important, it doesn’t
make sense to start therapy until you
are ready and committed to it.
Making a decision about what cri-
teria you will use as a basis for starting
therapy (of any kind, anti-HIV therapy,
herbal therapy, etc.) puts the decision
and control over using therapy in your
hands. Making decisions about com-
plementary therapies are often more
difficult and complex because there’s
a lack of information from studies to
help guide decision-making. (Read
Project Inform’s publication entitled
Herbs, Supplements and HIV.)
For example, you might decide
to start an herbal therapy right now,
regardless of your CD4+ cell count,
your viral load and your overall gen-
eral health. Or, you might decide to
start anti-HIV therapy if your CD4+
cell count has a decreasing trend to
below 350 and/or your viral load con-
tinues to rise above 50,000 and/or you
begin to experience symptoms associ-
ated with HIV disease. Deciding on
your own criteria, with the guidance
of your doctor, lets you be in control
of your treatment decisions.
How to monitor whether
therapy is working for you?
Before you start any kind of therapy, it’s
important to have realistic expectations
around what the therapy will do and
to determine how you will monitor to
decide if it is working. In terms of anti-
HIV therapy, typically you will look for
decreases in viral levels (HIV RNA),
increases in measure of immune health
(CD4+ cell counts) and improvements
in your overall general health.
Determining whether a complement-
ary therapy is working, when it doesn’t
have any direct anti-HIV activity, can
be difficult. How will you decide if that
you determine if it’s worth your money
(Remember, just because something is
available over-the-counter doesn’t mean
that there are no risks associated with
using it!)
choosing the best time to start
The following factors can help you and your provider
when choosing the best time for YOU to start therapy:
 CD4+ TREND CD4+ cell count trends (consistently decreasing
CD4+ cell counts, over time, indicate immune health is declining);
the most recent guidelines suggest that anti-HIV treatment should
be encouraged when the counts fall consistently below 350 (some
guidelines recommend waiting until 200);
 VIRAL LOAD TREND Trends in viral load (consistently increasing
HIV RNA levels, overtime, indicate that the virus is becoming more
active; this may either cause more damage to the immune system or
might be a signal that the immune system is failing already);
 GENERAL HEALTH Overall general health and the presence or
absence of minor symptoms; and
 YOUR READINESS TO START: You should begin treatment when
you’re ready for the demands of treatment. Without a strong basic
commitment, you’re likely develop poor adherence to your therapy.
Once you’ve made a
treatment decision, consider …
© PROJECT INFORM 1375 MISSION STREET SAN FRANCISCO, CA 94103-2621 415-558-8669 FAX 415-558-0684 SUPPORT@PROJECTINFORM.ORG WWW.PROJECTINFORM.ORG
MAKINGDECISIONS.JANUARY2007.PROJECTINFORM
7
Talk to your doctor and work
together to develop realistic ways of
determining if the therapy you want
to start is working. If after some
agreed upon period of time you are
not achieving your goals, agree to
revisit the use of the therapy approach
you are trying. Have these discussions
before you start taking the therapy.
How to monitor for (and manage)
potential side effects?
Before you start a given therapy, learn
about potential side effects, how to
monitor for them and how to manage
them. Recognize that there is almost
no such thing as a drug that doesn’t
have side effects. Even aspirin can
have potentially fatal side effects if
used constantly. Moreover, despite the
claims of advertisers, many herbs and
supple-ments can have side effects,
some of them serious.
Many people who start or switch to
a new anti-HIV therapy will experi-
ence some side effects or symptoms.
These may include headache, nausea,
diarrhea and tension. Often these
types of effects go away within four to
six weeks. It’s unclear how much of
these types of side effects are associ-
ated with the therapies and the body
adjusting to the medication and how
much they are due to stress and anxi-
ety associated with being on therapy.
Not everyone experiences these
effects. Some therapies have poten-
tially life-threatening side effects that
occur very rarely. Being aware of early
signs of these side effects and what to
do if they arise is important. More-
over, if you have a very clear under-
standing of what the potential side
effects of a given therapy are, you can
prepare to manage them should they
arise. (Read Project Inform’s Drug
Side Effects Chart.)
Talking with your doctor about side
effect before you start a therapy allows
you to have realistic expectations and
come up with criteria around when you
might consider stopping or switching
therapies based on side effects concerns.
You will be able to more fully parti-
cipate in monitoring for side effects
and identifying early signs of side
effects and possibly intervene before
they become a problem.
When to switch therapy and what
you might switch to (if necessary)?
In developing a long-term strategy for
treating HIV disease and managing
your health, it’s a good idea to think
ahead and be prepared. Fortunately,
many people are making strategic
decisions about therapy that look years
into the future instead of days or weeks.
even more seriously about how the
therapies they start today will affect
the options available to them later.
Consider what you might do in
terms of treatment if your first option
doesn’t work, causes too many side
effects or for other reasons doesn’t fit
with your lifestyle. Again, being pre-
pared and thinking about this before
the power of the mind
Studies show that more than one-third of people who receive a placebo (a sugar pill
with no medicinal value) receive some of the benefits as people taking a real drug.
This is because they believe that what they are taking is good for them.
If you believe that a particular therapy is “poison,” chances are greater that
you’ll experience side effects and won’t do as well on that therapy. If you believe
that something you’re doing is good for you, chances are greater that you’ll experi-
ence benefit and have an overall better experience with the therapy (like fewer side
effects). Do not underestimate the power of the mind in health and healing. It can
really make a difference!
the need for a change arises gives you
time to learn even more about your
next choice and takes some of the
anxiety away from facing a situation
where you might need to consider
switching to a new therapy regimen.
When to stop?
For the same reasons that it’s important
to decide when to start therapy, it’s also
important to consider when or if it’s
ever appropriate for you to stop, for any
length of time. How do you determine
when a given therapy or approach just
you say that the cost or potential risks
associated with using the therapy isn’t
worth the potential benefits of staying
you start therapy to develop some
criteria around this, that you both feel
comfortable with, is important.
In all of these areas you might come
todecisionsandagreementsthatchange
overtime. Your expectations of a given
therapy may change as you learn
more about it and as new information
becomes available. Changing your mind
and re-thinking your strategies and
approach is a healthy and normal part
of evolving a decision-making process.
some final words on making decisions
For most people, the idea of having a decision-
making process around healthcare is a new concept.
The vast majority of us have done as we we’re told
when it comes to healthcare decisions. If the doctor
prescribed a pill, we simply took it. (Or we didn’t,
but we probably didn’t tell the doctor!)
Participating with your doctor—in choosing
therapies and monitoring for side effects and the
effectiveness of a therapy—is a new experience for
most people. It’s not something that all doctors feel
comfortable with nor is it something that many
people immediately feel comfortable with either.
Studies have shown, however, that people who
participate in their healthcare decisions and form a
partnership with an HIV-experienced doctor, tend
to do better.
While information about HIV and the various
options for managing HIV disease can at times
seem overwhelming, developing a decision-making
process around treatment is not a mystery. In fact,
the general principals of decision-making around
your health and treatment choices are the same
principals that you probably already apply in many
areas of your life.
TOLL-FREE NATIONAL HIV/AIDS TREATMENT HOTLINE 1-800-822-7422 LOCAL AND INTERNATIONAL 415-558-9051 MONDAY–FRIDAY 10–4 PACIFIC TIME
MAKINGDECISIONS.JANUARY2007.PROJECTINFORM
8
In essence,
Once you’ve decided what you want to do, next decide:
for benefit), and
Moreover, plan ahead:
This type of decision-making process can be
applied to any kind of therapy approach, be it
pharmaceutical drugs, complementary therapy or
alternative systems of healing. Participating as a
full partner in your treatment decisions offers many
benefits, but it also takes effort on your part. The
likelihood of benefiting from therapy increases and
the likelihood of experiencing serious side effects
from therapy decreases when you’re involved in
decision-making and monitoring.

More Related Content

What's hot

Patient engagement in medication safety at the point of care – roles, respons...
Patient engagement in medication safety at the point of care – roles, respons...Patient engagement in medication safety at the point of care – roles, respons...
Patient engagement in medication safety at the point of care – roles, respons...
Canadian Patient Safety Institute
 
DR CHRISTOS KOUIMTSIDIS - ALCOHOL MISUSE IN SPECIAL POPULATIONS: INTELLECTUAL...
DR CHRISTOS KOUIMTSIDIS - ALCOHOL MISUSE IN SPECIAL POPULATIONS: INTELLECTUAL...DR CHRISTOS KOUIMTSIDIS - ALCOHOL MISUSE IN SPECIAL POPULATIONS: INTELLECTUAL...
DR CHRISTOS KOUIMTSIDIS - ALCOHOL MISUSE IN SPECIAL POPULATIONS: INTELLECTUAL...
iCAADEvents
 
Screening for Distress versus Providing Supportive Care: Avoiding a Conflict
Screening for Distress versus Providing Supportive Care: Avoiding a ConflictScreening for Distress versus Providing Supportive Care: Avoiding a Conflict
Screening for Distress versus Providing Supportive Care: Avoiding a Conflict
James Coyne
 
What Social Media Can Tell Us About The Patient Journey
What Social Media Can Tell Us About The Patient JourneyWhat Social Media Can Tell Us About The Patient Journey
What Social Media Can Tell Us About The Patient Journey
e-Patient Connections
 
MedicalResearch.com: Medical Research Exclusive Interviews December 31 2014
MedicalResearch.com:  Medical Research Exclusive Interviews December 31 2014MedicalResearch.com:  Medical Research Exclusive Interviews December 31 2014
MedicalResearch.com: Medical Research Exclusive Interviews December 31 2014
Marie Benz MD FAAD
 
MedicalResearch.com Leading Medical Research Interviews August 24 2015
MedicalResearch.com Leading Medical Research Interviews August 24 2015MedicalResearch.com Leading Medical Research Interviews August 24 2015
MedicalResearch.com Leading Medical Research Interviews August 24 2015
Marie Benz
 
Rx16 pharma tues_200_1_kelly_2ream_3shanehsaz
Rx16 pharma tues_200_1_kelly_2ream_3shanehsazRx16 pharma tues_200_1_kelly_2ream_3shanehsaz
Rx16 pharma tues_200_1_kelly_2ream_3shanehsaz
OPUNITE
 
Understanding advance directives
Understanding advance directivesUnderstanding advance directives
Understanding advance directives
Robert J Miller MD
 
MedicalResearch.com: Medical Research Interviews September12 2014
MedicalResearch.com:  Medical Research Interviews September12 2014MedicalResearch.com:  Medical Research Interviews September12 2014
MedicalResearch.com: Medical Research Interviews September12 2014
Marie Benz MD FAAD
 
Pulmonary Fibrosis Patient/Caregiver Experience​ Survey
Pulmonary Fibrosis Patient/Caregiver Experience​ SurveyPulmonary Fibrosis Patient/Caregiver Experience​ Survey
Pulmonary Fibrosis Patient/Caregiver Experience​ Survey
Inspire
 
Revised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebran
Revised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebranRevised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebran
Revised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebran
OPUNITE
 
Przybysz, reinhardt ph rgroupproject_fall_2012
Przybysz, reinhardt ph rgroupproject_fall_2012Przybysz, reinhardt ph rgroupproject_fall_2012
Przybysz, reinhardt ph rgroupproject_fall_2012
jlreinhardt
 
Va open notes and blue button va ehealth university dec 2012
Va open notes and blue button va ehealth university dec 2012Va open notes and blue button va ehealth university dec 2012
Va open notes and blue button va ehealth university dec 2012
Susan Woods
 
The 2014 Digital Patient Journey
The 2014 Digital Patient JourneyThe 2014 Digital Patient Journey
The 2014 Digital Patient Journey
Fathom: A Digital Marketing Agency
 
Linkage to Care Strategies
Linkage to Care StrategiesLinkage to Care Strategies
Linkage to Care Strategies
Randi Sylve
 
Antiretroviral Medication Adherence
Antiretroviral Medication AdherenceAntiretroviral Medication Adherence
Antiretroviral Medication Adherence
CDC NPIN
 
Voice of the Empowered Patient: An Analysis of the Inspire Annual Survey
Voice of the Empowered Patient:  An Analysis of the Inspire Annual SurveyVoice of the Empowered Patient:  An Analysis of the Inspire Annual Survey
Voice of the Empowered Patient: An Analysis of the Inspire Annual Survey
Inspire
 
Factors that Influence Adherence to HAART - Naicker MH
Factors that Influence Adherence to HAART - Naicker MHFactors that Influence Adherence to HAART - Naicker MH
Factors that Influence Adherence to HAART - Naicker MH
michaela naicker
 
Think Global, Act Local: Patient and Family Engagement Strategies & Contribut...
Think Global, Act Local: Patient and Family Engagement Strategies & Contribut...Think Global, Act Local: Patient and Family Engagement Strategies & Contribut...
Think Global, Act Local: Patient and Family Engagement Strategies & Contribut...
Canadian Patient Safety Institute
 
You Are Not Alone
You Are Not AloneYou Are Not Alone
You Are Not Alone
Nicole Marie Turcotte
 

What's hot (20)

Patient engagement in medication safety at the point of care – roles, respons...
Patient engagement in medication safety at the point of care – roles, respons...Patient engagement in medication safety at the point of care – roles, respons...
Patient engagement in medication safety at the point of care – roles, respons...
 
DR CHRISTOS KOUIMTSIDIS - ALCOHOL MISUSE IN SPECIAL POPULATIONS: INTELLECTUAL...
DR CHRISTOS KOUIMTSIDIS - ALCOHOL MISUSE IN SPECIAL POPULATIONS: INTELLECTUAL...DR CHRISTOS KOUIMTSIDIS - ALCOHOL MISUSE IN SPECIAL POPULATIONS: INTELLECTUAL...
DR CHRISTOS KOUIMTSIDIS - ALCOHOL MISUSE IN SPECIAL POPULATIONS: INTELLECTUAL...
 
Screening for Distress versus Providing Supportive Care: Avoiding a Conflict
Screening for Distress versus Providing Supportive Care: Avoiding a ConflictScreening for Distress versus Providing Supportive Care: Avoiding a Conflict
Screening for Distress versus Providing Supportive Care: Avoiding a Conflict
 
What Social Media Can Tell Us About The Patient Journey
What Social Media Can Tell Us About The Patient JourneyWhat Social Media Can Tell Us About The Patient Journey
What Social Media Can Tell Us About The Patient Journey
 
MedicalResearch.com: Medical Research Exclusive Interviews December 31 2014
MedicalResearch.com:  Medical Research Exclusive Interviews December 31 2014MedicalResearch.com:  Medical Research Exclusive Interviews December 31 2014
MedicalResearch.com: Medical Research Exclusive Interviews December 31 2014
 
MedicalResearch.com Leading Medical Research Interviews August 24 2015
MedicalResearch.com Leading Medical Research Interviews August 24 2015MedicalResearch.com Leading Medical Research Interviews August 24 2015
MedicalResearch.com Leading Medical Research Interviews August 24 2015
 
Rx16 pharma tues_200_1_kelly_2ream_3shanehsaz
Rx16 pharma tues_200_1_kelly_2ream_3shanehsazRx16 pharma tues_200_1_kelly_2ream_3shanehsaz
Rx16 pharma tues_200_1_kelly_2ream_3shanehsaz
 
Understanding advance directives
Understanding advance directivesUnderstanding advance directives
Understanding advance directives
 
MedicalResearch.com: Medical Research Interviews September12 2014
MedicalResearch.com:  Medical Research Interviews September12 2014MedicalResearch.com:  Medical Research Interviews September12 2014
MedicalResearch.com: Medical Research Interviews September12 2014
 
Pulmonary Fibrosis Patient/Caregiver Experience​ Survey
Pulmonary Fibrosis Patient/Caregiver Experience​ SurveyPulmonary Fibrosis Patient/Caregiver Experience​ Survey
Pulmonary Fibrosis Patient/Caregiver Experience​ Survey
 
Revised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebran
Revised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebranRevised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebran
Revised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebran
 
Przybysz, reinhardt ph rgroupproject_fall_2012
Przybysz, reinhardt ph rgroupproject_fall_2012Przybysz, reinhardt ph rgroupproject_fall_2012
Przybysz, reinhardt ph rgroupproject_fall_2012
 
Va open notes and blue button va ehealth university dec 2012
Va open notes and blue button va ehealth university dec 2012Va open notes and blue button va ehealth university dec 2012
Va open notes and blue button va ehealth university dec 2012
 
The 2014 Digital Patient Journey
The 2014 Digital Patient JourneyThe 2014 Digital Patient Journey
The 2014 Digital Patient Journey
 
Linkage to Care Strategies
Linkage to Care StrategiesLinkage to Care Strategies
Linkage to Care Strategies
 
Antiretroviral Medication Adherence
Antiretroviral Medication AdherenceAntiretroviral Medication Adherence
Antiretroviral Medication Adherence
 
Voice of the Empowered Patient: An Analysis of the Inspire Annual Survey
Voice of the Empowered Patient:  An Analysis of the Inspire Annual SurveyVoice of the Empowered Patient:  An Analysis of the Inspire Annual Survey
Voice of the Empowered Patient: An Analysis of the Inspire Annual Survey
 
Factors that Influence Adherence to HAART - Naicker MH
Factors that Influence Adherence to HAART - Naicker MHFactors that Influence Adherence to HAART - Naicker MH
Factors that Influence Adherence to HAART - Naicker MH
 
Think Global, Act Local: Patient and Family Engagement Strategies & Contribut...
Think Global, Act Local: Patient and Family Engagement Strategies & Contribut...Think Global, Act Local: Patient and Family Engagement Strategies & Contribut...
Think Global, Act Local: Patient and Family Engagement Strategies & Contribut...
 
You Are Not Alone
You Are Not AloneYou Are Not Alone
You Are Not Alone
 

Viewers also liked

Smart eating
Smart eatingSmart eating
Smart eating
Positive Life
 
After you test positive booklet
After you test positive bookletAfter you test positive booklet
After you test positive booklet
Positive Life
 
Herbs, supplimenats and hiv
Herbs, supplimenats and hivHerbs, supplimenats and hiv
Herbs, supplimenats and hiv
Positive Life
 
Usiing dietary supplements wisely
Usiing dietary supplements wiselyUsiing dietary supplements wisely
Usiing dietary supplements wisely
Positive Life
 
Eat real food
Eat real foodEat real food
Eat real food
Positive Life
 
Living In An Era of HIV
Living In An Era of HIVLiving In An Era of HIV
Living In An Era of HIV
Positive Life
 
Lab investig
Lab investigLab investig
Lab investig
Mona Mustafa
 

Viewers also liked (7)

Smart eating
Smart eatingSmart eating
Smart eating
 
After you test positive booklet
After you test positive bookletAfter you test positive booklet
After you test positive booklet
 
Herbs, supplimenats and hiv
Herbs, supplimenats and hivHerbs, supplimenats and hiv
Herbs, supplimenats and hiv
 
Usiing dietary supplements wisely
Usiing dietary supplements wiselyUsiing dietary supplements wisely
Usiing dietary supplements wisely
 
Eat real food
Eat real foodEat real food
Eat real food
 
Living In An Era of HIV
Living In An Era of HIVLiving In An Era of HIV
Living In An Era of HIV
 
Lab investig
Lab investigLab investig
Lab investig
 

Similar to Making decisions about therapies

Makingdecisionsabouttherapies 110914180647 Phpapp02
Makingdecisionsabouttherapies 110914180647 Phpapp02Makingdecisionsabouttherapies 110914180647 Phpapp02
Makingdecisionsabouttherapies 110914180647 Phpapp02
Positive Life
 
Building a Doctor-Patient Relationship (Additional PLUS Reading Materials)
Building a Doctor-Patient Relationship (Additional PLUS Reading Materials)Building a Doctor-Patient Relationship (Additional PLUS Reading Materials)
Building a Doctor-Patient Relationship (Additional PLUS Reading Materials)
Positive_Force
 
Making Decisions About Therapies (Additional PLUS Reading Materials)
Making Decisions About Therapies (Additional PLUS Reading Materials)Making Decisions About Therapies (Additional PLUS Reading Materials)
Making Decisions About Therapies (Additional PLUS Reading Materials)
Positive_Force
 
Vaccine hesitancy seminar primary care february 2021 v2
Vaccine hesitancy seminar primary care february 2021 v2Vaccine hesitancy seminar primary care february 2021 v2
Vaccine hesitancy seminar primary care february 2021 v2
Professor Jim McManus AFBPsS,FFPH,CSci, FRSB, CPsychol
 
New year
New yearNew year
New year
Surgerica
 
Patient Centered IT meets APPS4HEALTH @ Cebit 2011
Patient Centered IT meets APPS4HEALTH @ Cebit 2011Patient Centered IT meets APPS4HEALTH @ Cebit 2011
Patient Centered IT meets APPS4HEALTH @ Cebit 2011
Patient Centered IT
 
TitleABC123 Version X1Program Case StudyInforma
TitleABC123 Version X1Program Case StudyInformaTitleABC123 Version X1Program Case StudyInforma
TitleABC123 Version X1Program Case StudyInforma
TakishaPeck109
 
Information Therapy For Treating Infertility
Information Therapy For Treating InfertilityInformation Therapy For Treating Infertility
Information Therapy For Treating Infertility
Dr Aniruddha Malpani
 
ICLE 2016 Health Literacy Presentation
ICLE 2016 Health Literacy PresentationICLE 2016 Health Literacy Presentation
ICLE 2016 Health Literacy Presentation
Christopher Trudeau
 
Thinking ahead again plain final
Thinking ahead again plain finalThinking ahead again plain final
Thinking ahead again plain final
Board Resource Center - BRC
 
Fix the Lack of Communication in Your Practice
Fix the Lack of Communication in Your PracticeFix the Lack of Communication in Your Practice
Fix the Lack of Communication in Your Practice
Jim Cucinotta
 
Consumer Attitudes About Comparative Effectiveness
Consumer Attitudes About Comparative EffectivenessConsumer Attitudes About Comparative Effectiveness
Consumer Attitudes About Comparative Effectiveness
MSL
 
Senior access to health information nahsl.2011
Senior access to health information nahsl.2011Senior access to health information nahsl.2011
Senior access to health information nahsl.2011
Tim Roberts
 
Senior access to health information nahsl.2011
Senior access to health information nahsl.2011Senior access to health information nahsl.2011
Senior access to health information nahsl.2011
Tim Roberts
 
Top 10 qualities a good doctor must have
Top 10 qualities a good doctor must haveTop 10 qualities a good doctor must have
Top 10 qualities a good doctor must have
Medical Transcription Service Company
 
Crimson Publishers-Pre-Exposure Prophylaxis for HIV Infection, is it Working?
Crimson Publishers-Pre-Exposure Prophylaxis for HIV Infection, is it Working? Crimson Publishers-Pre-Exposure Prophylaxis for HIV Infection, is it Working?
Crimson Publishers-Pre-Exposure Prophylaxis for HIV Infection, is it Working?
CrimsonPublishers-PRM
 
Information Therapy and the Empowered Patient
Information Therapy and the Empowered PatientInformation Therapy and the Empowered Patient
Information Therapy and the Empowered Patient
Dr Aniruddha Malpani
 
Information Therapy
Information TherapyInformation Therapy
Information Therapy
Dr Aniruddha Malpani
 
Information Therapy and the Empowered Patient
Information Therapy  and the Empowered PatientInformation Therapy  and the Empowered Patient
Information Therapy and the Empowered Patient
Dr Aniruddha Malpani
 
Primary Care Physician.docx
Primary Care Physician.docxPrimary Care Physician.docx
Primary Care Physician.docx
karismed4
 

Similar to Making decisions about therapies (20)

Makingdecisionsabouttherapies 110914180647 Phpapp02
Makingdecisionsabouttherapies 110914180647 Phpapp02Makingdecisionsabouttherapies 110914180647 Phpapp02
Makingdecisionsabouttherapies 110914180647 Phpapp02
 
Building a Doctor-Patient Relationship (Additional PLUS Reading Materials)
Building a Doctor-Patient Relationship (Additional PLUS Reading Materials)Building a Doctor-Patient Relationship (Additional PLUS Reading Materials)
Building a Doctor-Patient Relationship (Additional PLUS Reading Materials)
 
Making Decisions About Therapies (Additional PLUS Reading Materials)
Making Decisions About Therapies (Additional PLUS Reading Materials)Making Decisions About Therapies (Additional PLUS Reading Materials)
Making Decisions About Therapies (Additional PLUS Reading Materials)
 
Vaccine hesitancy seminar primary care february 2021 v2
Vaccine hesitancy seminar primary care february 2021 v2Vaccine hesitancy seminar primary care february 2021 v2
Vaccine hesitancy seminar primary care february 2021 v2
 
New year
New yearNew year
New year
 
Patient Centered IT meets APPS4HEALTH @ Cebit 2011
Patient Centered IT meets APPS4HEALTH @ Cebit 2011Patient Centered IT meets APPS4HEALTH @ Cebit 2011
Patient Centered IT meets APPS4HEALTH @ Cebit 2011
 
TitleABC123 Version X1Program Case StudyInforma
TitleABC123 Version X1Program Case StudyInformaTitleABC123 Version X1Program Case StudyInforma
TitleABC123 Version X1Program Case StudyInforma
 
Information Therapy For Treating Infertility
Information Therapy For Treating InfertilityInformation Therapy For Treating Infertility
Information Therapy For Treating Infertility
 
ICLE 2016 Health Literacy Presentation
ICLE 2016 Health Literacy PresentationICLE 2016 Health Literacy Presentation
ICLE 2016 Health Literacy Presentation
 
Thinking ahead again plain final
Thinking ahead again plain finalThinking ahead again plain final
Thinking ahead again plain final
 
Fix the Lack of Communication in Your Practice
Fix the Lack of Communication in Your PracticeFix the Lack of Communication in Your Practice
Fix the Lack of Communication in Your Practice
 
Consumer Attitudes About Comparative Effectiveness
Consumer Attitudes About Comparative EffectivenessConsumer Attitudes About Comparative Effectiveness
Consumer Attitudes About Comparative Effectiveness
 
Senior access to health information nahsl.2011
Senior access to health information nahsl.2011Senior access to health information nahsl.2011
Senior access to health information nahsl.2011
 
Senior access to health information nahsl.2011
Senior access to health information nahsl.2011Senior access to health information nahsl.2011
Senior access to health information nahsl.2011
 
Top 10 qualities a good doctor must have
Top 10 qualities a good doctor must haveTop 10 qualities a good doctor must have
Top 10 qualities a good doctor must have
 
Crimson Publishers-Pre-Exposure Prophylaxis for HIV Infection, is it Working?
Crimson Publishers-Pre-Exposure Prophylaxis for HIV Infection, is it Working? Crimson Publishers-Pre-Exposure Prophylaxis for HIV Infection, is it Working?
Crimson Publishers-Pre-Exposure Prophylaxis for HIV Infection, is it Working?
 
Information Therapy and the Empowered Patient
Information Therapy and the Empowered PatientInformation Therapy and the Empowered Patient
Information Therapy and the Empowered Patient
 
Information Therapy
Information TherapyInformation Therapy
Information Therapy
 
Information Therapy and the Empowered Patient
Information Therapy  and the Empowered PatientInformation Therapy  and the Empowered Patient
Information Therapy and the Empowered Patient
 
Primary Care Physician.docx
Primary Care Physician.docxPrimary Care Physician.docx
Primary Care Physician.docx
 

More from Positive Life

Complimentry and aternative medicine continued
Complimentry and aternative medicine continuedComplimentry and aternative medicine continued
Complimentry and aternative medicine continued
Positive Life
 
Complimentary and alternative medicine
Complimentary and alternative medicineComplimentary and alternative medicine
Complimentary and alternative medicine
Positive Life
 
Dealing with drug side effects
Dealing with drug side effectsDealing with drug side effects
Dealing with drug side effects
Positive Life
 
Adherence
AdherenceAdherence
Adherence
Positive Life
 
Consideringtreatmentandyourhealthcare 130129172100-phpapp01
Consideringtreatmentandyourhealthcare 130129172100-phpapp01Consideringtreatmentandyourhealthcare 130129172100-phpapp01
Consideringtreatmentandyourhealthcare 130129172100-phpapp01
Positive Life
 
Usiing dietary supplements wisely
Usiing dietary supplements wiselyUsiing dietary supplements wisely
Usiing dietary supplements wisely
Positive Life
 
Now that you've started treatment
Now that you've started treatmentNow that you've started treatment
Now that you've started treatment
Positive Life
 
Whats New Hiv Treatment Guidlines
Whats New   Hiv Treatment GuidlinesWhats New   Hiv Treatment Guidlines
Whats New Hiv Treatment Guidlines
Positive Life
 
Std2011plus2 111204122105 Phpapp02
Std2011plus2 111204122105 Phpapp02Std2011plus2 111204122105 Phpapp02
Std2011plus2 111204122105 Phpapp02
Positive Life
 
Winter Nutrition
Winter NutritionWinter Nutrition
Winter Nutrition
Positive Life
 
Hivtreatmentdecember2011 111204184012 Phpapp02
Hivtreatmentdecember2011 111204184012 Phpapp02Hivtreatmentdecember2011 111204184012 Phpapp02
Hivtreatmentdecember2011 111204184012 Phpapp02
Positive Life
 
Hiv Lifecycle
Hiv LifecycleHiv Lifecycle
Hiv Lifecycle
Positive Life
 
Dealingwithsideeffects 110914180652 Phpapp02
Dealingwithsideeffects 110914180652 Phpapp02Dealingwithsideeffects 110914180652 Phpapp02
Dealingwithsideeffects 110914180652 Phpapp02
Positive Life
 
Advocacy And Hiv 1
Advocacy And Hiv 1Advocacy And Hiv 1
Advocacy And Hiv 1
Positive Life
 
Adherence 110914180412 Phpapp02
Adherence 110914180412 Phpapp02Adherence 110914180412 Phpapp02
Adherence 110914180412 Phpapp02
Positive Life
 
12 Steps
12 Steps12 Steps
12 Steps
Positive Life
 

More from Positive Life (16)

Complimentry and aternative medicine continued
Complimentry and aternative medicine continuedComplimentry and aternative medicine continued
Complimentry and aternative medicine continued
 
Complimentary and alternative medicine
Complimentary and alternative medicineComplimentary and alternative medicine
Complimentary and alternative medicine
 
Dealing with drug side effects
Dealing with drug side effectsDealing with drug side effects
Dealing with drug side effects
 
Adherence
AdherenceAdherence
Adherence
 
Consideringtreatmentandyourhealthcare 130129172100-phpapp01
Consideringtreatmentandyourhealthcare 130129172100-phpapp01Consideringtreatmentandyourhealthcare 130129172100-phpapp01
Consideringtreatmentandyourhealthcare 130129172100-phpapp01
 
Usiing dietary supplements wisely
Usiing dietary supplements wiselyUsiing dietary supplements wisely
Usiing dietary supplements wisely
 
Now that you've started treatment
Now that you've started treatmentNow that you've started treatment
Now that you've started treatment
 
Whats New Hiv Treatment Guidlines
Whats New   Hiv Treatment GuidlinesWhats New   Hiv Treatment Guidlines
Whats New Hiv Treatment Guidlines
 
Std2011plus2 111204122105 Phpapp02
Std2011plus2 111204122105 Phpapp02Std2011plus2 111204122105 Phpapp02
Std2011plus2 111204122105 Phpapp02
 
Winter Nutrition
Winter NutritionWinter Nutrition
Winter Nutrition
 
Hivtreatmentdecember2011 111204184012 Phpapp02
Hivtreatmentdecember2011 111204184012 Phpapp02Hivtreatmentdecember2011 111204184012 Phpapp02
Hivtreatmentdecember2011 111204184012 Phpapp02
 
Hiv Lifecycle
Hiv LifecycleHiv Lifecycle
Hiv Lifecycle
 
Dealingwithsideeffects 110914180652 Phpapp02
Dealingwithsideeffects 110914180652 Phpapp02Dealingwithsideeffects 110914180652 Phpapp02
Dealingwithsideeffects 110914180652 Phpapp02
 
Advocacy And Hiv 1
Advocacy And Hiv 1Advocacy And Hiv 1
Advocacy And Hiv 1
 
Adherence 110914180412 Phpapp02
Adherence 110914180412 Phpapp02Adherence 110914180412 Phpapp02
Adherence 110914180412 Phpapp02
 
12 Steps
12 Steps12 Steps
12 Steps
 

Recently uploaded

CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
Swastik Ayurveda
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
chandankumarsmartiso
 

Recently uploaded (20)

CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
 

Making decisions about therapies

  • 1. © PROJECT INFORM 1375 MISSION STREET SAN FRANCISCO, CA 94103-2621 415-558-8669 FAX 415-558-0684 SUPPORT@PROJECTINFORM.ORG WWW.PROJECTINFORM.ORG MAKING DECISIONS ABOUT THERAPIES  issues to consider when developing your personal treatment plan Making decisions about treating HIV can sometimes feel overwhelming. Developing a personal plan to help you think about, plan for and make treatment decisions can help. Whether considering pharmaceutical drugs or complementary therapies, it’s important that your plan is one you’re comfortable with and feel empowered by. This publication focuses on issues to consider when developing your treatment decision-making plan. WHAT’S INSIDE The basis for making a decision: 2; Choosing a doctor: 3; Learn about HIV disease and your treatment options: 4–5; Information, consider the source: 5; Once you’ve made a treatment decision, consider ... : 6–7; Choosing the best time to start: 6; The power of the mind: 7; Some final words on making decisions: 8. PUBLISHED BY JANUARY 2007
  • 2. TOLL-FREE NATIONAL HIV/AIDS TREATMENT HOTLINE 1-800-822-7422 LOCAL AND INTERNATIONAL 415-558-9051 MONDAY–FRIDAY 10–4 PACIFIC TIME MAKINGDECISIONS.JANUARY2007.PROJECTINFORM 2 the basis for making decisions Regardless of the therapy you consider, the same basic principals for making decisions can be used, including:  CHOOSE AN EXPERIENCED PROVIDER. Choose a healthcare provider or doctor who is experienced with the treatment of HIV disease and with the types of therapy you are interested in pursuing.  DEVELOP THE RIGHT RELATIONSHIP. Learn about the different types of doctor/ patient relationships; determine how you want to interact with your doctor and develop the right relationship. Discuss your decision-making process style of relationship with your healthcare provider.  GET INFORMED! Learn about your health condition(s) and possible treatment options: sources of information that give you objective information about various treatments and strategies. Project Inform offers this kind of information free-of-charge through a toll-free hotline, printed documents, public meetings and website.  TALK BEFORE YOU START. Talk to your doctor before you start therapy (regardless of what that therapy is) and come to mutual agreements about:
  • 3. © PROJECT INFORM 1375 MISSION STREET SAN FRANCISCO, CA 94103-2621 415-558-8669 FAX 415-558-0684 SUPPORT@PROJECTINFORM.ORG WWW.PROJECTINFORM.ORG MAKINGDECISIONS.JANUARY2007.PROJECTINFORM 3 Finding a doctor who has experience treatingpeoplelivingwithHIVisvery important. Studies have shown that people with HIV who see doctors experienced in treating people with HIV are more likely to be long-term survivors than those with inexperi- enced doctors. According to these studies, an HIV-experienced doctor is someone who has five or more people in their practice who are living with HIV, though in general, the more experi- ence and patients the physician has, the better. Consider five a minimum. Experienced doctors will usually have more skill in prescribing and monitoring anti-HIV drugs wisely, and are also more likely to wisely prescribed preventative therapies. cological and pregnancy concerns, choosing an experienced gynecologist and/or obstetrician is also important. In some cases, choosing a highly HIV-experienced doctor is not poss- ible. This is especially true in rural settings where HIV-positive people may be more isolated than in major cities. This does not mean that one need receive less than optimal care. Even in the most rural settings, there is usually at least one healthcare provider who has worked with HIV- positive people. Some experience is better than none. However, it may mean that the patient and doctor need to be more diligent in learning about HIV, keeping up to date on the latest in treatment information and finding appropriate resources. Developing an open and comfortable relationship will help this ongoing process. Often, people liv- ing with HIV in such situa-tions play an important role in keep- ing their doctors up to date by bringing them new information, reports from medical conferences and resources available from groups like Project Inform. While doctors may some-times at first be inclined to reject information from anyone other than doctors, they often get over this prejudice when they realize that, at least in HIV disease, community groups andresourcesoftenhavebetter accessto information, and more time for reviewing it, than they do. Many physicians come to welcome the input their patients can bring them. Finally, the general principal of choosing an HIV-experienced doctor applies to practitioners of alternative systems of healing as well, like tra- ditional Chinese medicine, herbal- ists, acupuncturists and other holis- tic healers. If you have an interest in complimentary or alternative thera- pies, the healthcare provider should have experience in their use in HIV- positive people, not just experience with therapies themselves. Some herbs and supplements, for example, can affect the way commonly used anti-HIV drugs are absorbed in the body, so knowledge of both types of therapy is critical. A doctor or healing practitioner who keeps up to date on literature about new discov-eries in our understanding of HIV disease and who has expe- rience treating people living with HIV is an important partner in your healthcare. developing a relationship with your doctor Working with your provider to develop a relationship that you both feel comfortable with is the next step. It’s important to trust your own reac- tions when deciding whether this doctor is the right one for you. But you also may want to give the relationship some time to develop. It takes more than one visit for you and your doctor to get to know each other. For more information on developing a relationship with a doctor, call Doctor/Patient Relationship. Choosing a doctor
  • 4. TOLL-FREE NATIONAL HIV/AIDS TREATMENT INFORMATION HOTLINE 1-800-822-7422 LOCAL/INTERNATIONAL 415-558-9051 MONDAY-FRIDAY 9-5 SATURDAY 10-4 PACIFIC TIME MAKINGDECISIONS.JANUARY2007.PROJECTINFORM 4 TOLL-FREE NATIONAL HIV/AIDS TREATMENT HOTLINE 1-800-822-7422 LOCAL AND INTERNATIONAL 415-558-9051 MONDAY–FRIDAY 10–4 PACIFIC TIME A key to participating in treatment decision making is to get informed about HIV disease, treatment options and overall strategies sooner rather than later. If a person waits too long before seeking medical care and has already come down with an opportunistic infection, there may be little time to learn about options since immediate treatment may be needed. Whenever possible, people should get informed about treatment strategies and option well before it’s time to start treatment.For more information about monitoring HIV disease, call Project Inform’s Hotline and ask for Day One. If you’re healthy and not feeling like you need or want to start therapy immediately, it’s still a good idea to learn about your treatment options and strategies and begin talking with your doctor about what to do and when to do it. Making those decisions before the problem is critical can diminish some of the fear that is often associated with starting any kind of therapy for the first time. Starting these discussions with your doctor is perhaps the best form of “early intervention” and will greatly increase the chances that you will avoid starting therapy either too early or too late. What does the research show? Getting informed and learning about HIV and your options and strategies may seem overwhelming at first. It’s not easy for anyone. Sometimes it’s hard to read about HIV disease and the information may sometimes seem like it’s written in a foreign language ... at first! One of the missions ofProject Inform is to provide under- standable information to people living with HIV. The staff at Project Inform spends hundreds of hours annually in medical libraries, attending medical conferences and ana- lyzing studies to learn about the latest advances and what they mean. We try our best to put that information together in a way that people who aren’t scientists or doctors can understand it. Some people think of Project Inform as a sort of Consumer Reports on HIV treatments. Though we do everything we can to make it the best source, Project Inform is not the only place to get information about HIV treatments and strate- gies, however. There are several newsletters and sources of HIV information, each with its own special benefits. For a list of references, call Project Inform’s Hotline and ask for Guide to HIV/AIDS Related Resources. The Project Inform Hotline operates Monday through Friday and vol- - tions you might have and mail you information, free of charge. Explore, examine and challenge your beliefs about therapy. Most people have concerns and fears about starting therapies, be they anti-HIV therapies or complementary herbal ther- apies. Learning about that therapy can sometimes lessen your concerns and help you decide whether it’s right for you. Consider how it might impact your lifestyle and whether any dietary restrictions may be a problem. Learn about poten- tial side effects and prepare for them, should they occur. In exploring your beliefs about a therapy, you might find that you have come to a conclusion based on personal fears or rumors. Grounding yourself in knowledge, rather than fears, and challenging where possibly unfounded beliefs might be clouding decision-making is critical. Challenging your beliefs and seeking their roots is important. Personal experi- ence and knowledge about a given therapy is far better infor- mation to inform decision-making than fears or conjecture. With that said, however, if you truly believe that a parti- cular approach may be more harmful to you than its poten- tial benefits, you might be better off considering another option. You can always revisit that decision at a later time. Don’t reject what you believe about therapy when it comes to making your decision—it should weigh in with other considerations but those beliefs should be explored, exam- ined and challenged. Get informed! Learn about HIV disease and ...
  • 5. © PROJECT INFORM 1375 MISSION STREET SAN FRANCISCO, CA 94103-2621 415-558-8669 FAX 415-558-0684 SUPPORT@PROJECTINFORM.ORG WWW.PROJECTINFORM.ORG MAKINGDECISIONS.JANUARY2007.PROJECTINFORM 5 What has been the experience of friends and people you trust? Learning about other people’s experience with a particular therapy or treatment-decision plan can help inform your own decisions. Talk to friends, people in support groups and others who are experiencing similar health conditions. Ask them about what kinds of treatments they’re using. Why did they choose those treatments and what have their But great caution should also be exercised when using the experiences of others as a source of information. The fewer people you ask, the less reliable that information will be. Remember, what works for one person won’t always work for you. Just because someone you know had a bad experi-ence—or a good one—with a particular therapy doesn’t mean that you will. There are many factors beyond our control that affect how each of us responds to a particular treatment strategy. The personal experiences of others should be only a piece of the pie as you gather information. The most reliable picture of a therapy’s actions will usually come from well-designed stud- ies, but even these cannot predict how you will respond. Does your healthcare provider have an opinion about the therapy option or strategy you’re con- sidering? If so, what is it and what is it based on? Ask your doctor about his or her experience with or opin- ions about the therapies and strategies you are considering. Does the doctor have advice about whether a particular about the different options you are hearing about and the information reported in sources such as newsletters. If you find that your doctor likes to put everyone on the same treatment, ask why. HIV treatment information and guidelines are not meant to be a cookbook, to be used the same way with everyone. Ask how you might develop a treat-ment strategy that takes your personal needs and concerns in mind. For more information on developing a relationship with your doctor, call Project Inform’s Hotline and ask for Building a Doctor/Patient Relationship. You can’t make an informed decision about treatments— regardless of what type of treatment you’re considering—if you’re not informed about all your options. Get as much information as possible, from a variety of credible sources that you trust. Learn about HIV and treatment options. It’s better to make an informed decision that you feel very com-fortable with than a hasty one. your treatment options! Information: consider the source As you’re learning about HIV and possible treatment approaches, be aware of false and misleading medical information and claims about therapies. When you’re reading about HIV and HIV treatments, consider the source of the information. Pharmaceuticalcompaniesthatmarket HIV therapies have an interest in selling products and may not always provide a balanced view of their products. Pharma- ceutical company advertising should be viewed with skepticism. Increasingly, community and physician forumsandeducationalmaterialsarebeing paid for with pharmaceutical money. Just because a pharmaceutical company sup- ports an educational forum doesn’t auto- matically mean that the information isn’t useful;butyouhavearighttoaskquestions about the speaker’s involvement with the company—likewhetherornottheyreceived money from the company. Consider how thatmightinfluencetheirabilitytoprovide unbiased information. There are many people who, under the guiseofalternative/complementaryther- apies, propose to have “cures” for HIV, cancer and many other life-threatening diseases. Often they will claim that they have a therapy that is being suppressed, shrouded in controversy and government conspiracy. In reality the vast majority of allsuchclaimsareoutrightfraud.Innearly all cases, individuals prey on the vulner- abilityandhopesofpeoplewhoarefright- ened and make a pretty penny in doing so. For more information, read Project Inform’s How To Identify AIDS Fraud.
  • 6. TOLL-FREE NATIONAL HIV/AIDS TREATMENT HOTLINE 1-800-822-7422 LOCAL AND INTERNATIONAL 415-558-9051 MONDAY–FRIDAY 10–4 PACIFIC TIME MAKINGDECISIONS.JANUARY2007.PROJECTINFORM 6 When to start? Starting any ther- apy can cause anxi- ety. There is no one proven “right” time to start anti-HIV therapy, for example, for everyone. There are differing opinions about starting therapy early in the course of HIV infection vs. later. Either choice In general, current thinking in the US and Europe is leaning in favor of delaying treatment until there has been a significant decline on CD4+ cell counts. The most recent research shows that this loss can usually be recovered when people start treatment. In contrast, starting treatment very early, before significant decline of CD4+ cell counts, can force people to begin using up the limited time that each drug will work, earlier than necessary. It may also lead to an earlier risk of developing both drug side effects and drug resistance. These cannot always be corrected so easily. (For more informa- tion, call Project Inform’s Hotline and ask for Anti-HIV Therapy Strategies). While there are instances where using anti-HIV therapies have clearly been shown to be beneficial, when to start therapy remains an individual decision. Most important, it doesn’t make sense to start therapy until you are ready and committed to it. Making a decision about what cri- teria you will use as a basis for starting therapy (of any kind, anti-HIV therapy, herbal therapy, etc.) puts the decision and control over using therapy in your hands. Making decisions about com- plementary therapies are often more difficult and complex because there’s a lack of information from studies to help guide decision-making. (Read Project Inform’s publication entitled Herbs, Supplements and HIV.) For example, you might decide to start an herbal therapy right now, regardless of your CD4+ cell count, your viral load and your overall gen- eral health. Or, you might decide to start anti-HIV therapy if your CD4+ cell count has a decreasing trend to below 350 and/or your viral load con- tinues to rise above 50,000 and/or you begin to experience symptoms associ- ated with HIV disease. Deciding on your own criteria, with the guidance of your doctor, lets you be in control of your treatment decisions. How to monitor whether therapy is working for you? Before you start any kind of therapy, it’s important to have realistic expectations around what the therapy will do and to determine how you will monitor to decide if it is working. In terms of anti- HIV therapy, typically you will look for decreases in viral levels (HIV RNA), increases in measure of immune health (CD4+ cell counts) and improvements in your overall general health. Determining whether a complement- ary therapy is working, when it doesn’t have any direct anti-HIV activity, can be difficult. How will you decide if that you determine if it’s worth your money (Remember, just because something is available over-the-counter doesn’t mean that there are no risks associated with using it!) choosing the best time to start The following factors can help you and your provider when choosing the best time for YOU to start therapy:  CD4+ TREND CD4+ cell count trends (consistently decreasing CD4+ cell counts, over time, indicate immune health is declining); the most recent guidelines suggest that anti-HIV treatment should be encouraged when the counts fall consistently below 350 (some guidelines recommend waiting until 200);  VIRAL LOAD TREND Trends in viral load (consistently increasing HIV RNA levels, overtime, indicate that the virus is becoming more active; this may either cause more damage to the immune system or might be a signal that the immune system is failing already);  GENERAL HEALTH Overall general health and the presence or absence of minor symptoms; and  YOUR READINESS TO START: You should begin treatment when you’re ready for the demands of treatment. Without a strong basic commitment, you’re likely develop poor adherence to your therapy. Once you’ve made a treatment decision, consider …
  • 7. © PROJECT INFORM 1375 MISSION STREET SAN FRANCISCO, CA 94103-2621 415-558-8669 FAX 415-558-0684 SUPPORT@PROJECTINFORM.ORG WWW.PROJECTINFORM.ORG MAKINGDECISIONS.JANUARY2007.PROJECTINFORM 7 Talk to your doctor and work together to develop realistic ways of determining if the therapy you want to start is working. If after some agreed upon period of time you are not achieving your goals, agree to revisit the use of the therapy approach you are trying. Have these discussions before you start taking the therapy. How to monitor for (and manage) potential side effects? Before you start a given therapy, learn about potential side effects, how to monitor for them and how to manage them. Recognize that there is almost no such thing as a drug that doesn’t have side effects. Even aspirin can have potentially fatal side effects if used constantly. Moreover, despite the claims of advertisers, many herbs and supple-ments can have side effects, some of them serious. Many people who start or switch to a new anti-HIV therapy will experi- ence some side effects or symptoms. These may include headache, nausea, diarrhea and tension. Often these types of effects go away within four to six weeks. It’s unclear how much of these types of side effects are associ- ated with the therapies and the body adjusting to the medication and how much they are due to stress and anxi- ety associated with being on therapy. Not everyone experiences these effects. Some therapies have poten- tially life-threatening side effects that occur very rarely. Being aware of early signs of these side effects and what to do if they arise is important. More- over, if you have a very clear under- standing of what the potential side effects of a given therapy are, you can prepare to manage them should they arise. (Read Project Inform’s Drug Side Effects Chart.) Talking with your doctor about side effect before you start a therapy allows you to have realistic expectations and come up with criteria around when you might consider stopping or switching therapies based on side effects concerns. You will be able to more fully parti- cipate in monitoring for side effects and identifying early signs of side effects and possibly intervene before they become a problem. When to switch therapy and what you might switch to (if necessary)? In developing a long-term strategy for treating HIV disease and managing your health, it’s a good idea to think ahead and be prepared. Fortunately, many people are making strategic decisions about therapy that look years into the future instead of days or weeks. even more seriously about how the therapies they start today will affect the options available to them later. Consider what you might do in terms of treatment if your first option doesn’t work, causes too many side effects or for other reasons doesn’t fit with your lifestyle. Again, being pre- pared and thinking about this before the power of the mind Studies show that more than one-third of people who receive a placebo (a sugar pill with no medicinal value) receive some of the benefits as people taking a real drug. This is because they believe that what they are taking is good for them. If you believe that a particular therapy is “poison,” chances are greater that you’ll experience side effects and won’t do as well on that therapy. If you believe that something you’re doing is good for you, chances are greater that you’ll experi- ence benefit and have an overall better experience with the therapy (like fewer side effects). Do not underestimate the power of the mind in health and healing. It can really make a difference! the need for a change arises gives you time to learn even more about your next choice and takes some of the anxiety away from facing a situation where you might need to consider switching to a new therapy regimen. When to stop? For the same reasons that it’s important to decide when to start therapy, it’s also important to consider when or if it’s ever appropriate for you to stop, for any length of time. How do you determine when a given therapy or approach just you say that the cost or potential risks associated with using the therapy isn’t worth the potential benefits of staying you start therapy to develop some criteria around this, that you both feel comfortable with, is important. In all of these areas you might come todecisionsandagreementsthatchange overtime. Your expectations of a given therapy may change as you learn more about it and as new information becomes available. Changing your mind and re-thinking your strategies and approach is a healthy and normal part of evolving a decision-making process.
  • 8. some final words on making decisions For most people, the idea of having a decision- making process around healthcare is a new concept. The vast majority of us have done as we we’re told when it comes to healthcare decisions. If the doctor prescribed a pill, we simply took it. (Or we didn’t, but we probably didn’t tell the doctor!) Participating with your doctor—in choosing therapies and monitoring for side effects and the effectiveness of a therapy—is a new experience for most people. It’s not something that all doctors feel comfortable with nor is it something that many people immediately feel comfortable with either. Studies have shown, however, that people who participate in their healthcare decisions and form a partnership with an HIV-experienced doctor, tend to do better. While information about HIV and the various options for managing HIV disease can at times seem overwhelming, developing a decision-making process around treatment is not a mystery. In fact, the general principals of decision-making around your health and treatment choices are the same principals that you probably already apply in many areas of your life. TOLL-FREE NATIONAL HIV/AIDS TREATMENT HOTLINE 1-800-822-7422 LOCAL AND INTERNATIONAL 415-558-9051 MONDAY–FRIDAY 10–4 PACIFIC TIME MAKINGDECISIONS.JANUARY2007.PROJECTINFORM 8 In essence, Once you’ve decided what you want to do, next decide: for benefit), and Moreover, plan ahead: This type of decision-making process can be applied to any kind of therapy approach, be it pharmaceutical drugs, complementary therapy or alternative systems of healing. Participating as a full partner in your treatment decisions offers many benefits, but it also takes effort on your part. The likelihood of benefiting from therapy increases and the likelihood of experiencing serious side effects from therapy decreases when you’re involved in decision-making and monitoring.